Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

375 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Correction: The Hippo pathway efector TAZ induces intrahepatic cholangiocarcinoma in mice and is ubiquitously activated in the human disease.
Cigliano A, Zhang S, Ribback S, Steinmann S, Sini M, Ament CE, Utpatel K, Song X, Wang J, Pilo MG, Berger F, Wang H, Tao J, Li X, Pes GM, Mancarella S, Giannelli G, Dombrowski F, Evert M, Calvisi DF, Chen X, Evert K. Cigliano A, et al. Among authors: giannelli g. J Exp Clin Cancer Res. 2023 May 17;42(1):124. doi: 10.1186/s13046-023-02709-x. J Exp Clin Cancer Res. 2023. PMID: 37194029 Free PMC article. No abstract available.
Aberrant fucosylation sustains the NOTCH and EGFR/NF-κB pathways and has a prognostic value in human intrahepatic cholangiocarcinoma.
Ament CE, Steinmann S, Evert K, Pes GM, Ribback S, Gigante I, Pizzuto E, Banales JM, Rodrigues PM, Olaizola P, Wang H, Giannelli G, Chen X, Evert M, Calvisi DF. Ament CE, et al. Among authors: giannelli g. Hepatology. 2023 Dec 1;78(6):1742-1754. doi: 10.1097/HEP.0000000000000322. Epub 2023 Feb 16. Hepatology. 2023. PMID: 36789652
Correction: CD90 is regulated by notch1 and hallmarks a more aggressive intrahepatic cholangiocarcinoma phenotype.
Mancarella S, Serino G, Gigante I, Cigliano A, Ribback S, Sanese P, Grossi V, Simone C, Armentano R, Evert M, Calvisi DF, Giannelli G. Mancarella S, et al. Among authors: giannelli g. J Exp Clin Cancer Res. 2023 Apr 18;42(1):88. doi: 10.1186/s13046-023-02661-w. J Exp Clin Cancer Res. 2023. PMID: 37069577 Free PMC article. No abstract available.
Upregulation of the oestrogen target gene SIX1 is associated with higher growth speed and decreased survival in HCV-positive women with hepatocellular carcinoma.
Critelli RM, Milosa F, Romanzi A, Lasagni S, Marcelli G, Di Marco L, Pivetti A, Schepis F, Romagnoli D, Mancarella S, Dituri F, Martinez-Chantar ML, Giannelli G, Villa E. Critelli RM, et al. Among authors: giannelli g. Oncol Lett. 2022 Sep 21;24(5):395. doi: 10.3892/ol.2022.13515. eCollection 2022 Nov. Oncol Lett. 2022. PMID: 36276500 Free PMC article.
Corrigendum: Associations between serum biomarkers and non-alcoholic liver disease: results of a clinical study of Mediterranean patients with obesity.
De Nucci S, Castellana F, Zupo R, Lampignano L, Di Chito M, Rinaldi R, Giannuzzi V, Cozzolongo R, Piazzolla G, Giannelli G, Sardone R, De Pergola G. De Nucci S, et al. Among authors: giannelli g. Front Nutr. 2023 May 4;10:1198144. doi: 10.3389/fnut.2023.1198144. eCollection 2023. Front Nutr. 2023. PMID: 37215206 Free PMC article.
GALAD outperforms aMAP and ALBI for predicting HCC in patients with compensated advanced chronic liver disease: A 12-year prospective study.
Villa E, Donghia R, Baldaccini V, Tedesco CC, Shahini E, Cozzolongo R, Ascari S, Pesole PL, Coletta S, Critelli RM, Lasagni S, Schepis F, Semellini F, Giannelli G. Villa E, et al. Among authors: giannelli g. Hepatol Commun. 2023 Sep 15;7(10):e0262. doi: 10.1097/HC9.0000000000000262. eCollection 2023 Oct 1. Hepatol Commun. 2023. PMID: 37708455 Free PMC article.
375 results